HOLX vs PATH
Hologic Inc (HOLX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HOLX and PATH stock pages for the full models.
Not investment advice.